Sivik Global Healthcare LLC Dexcom Inc Transaction History

Sivik Global Healthcare LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$110.31 - $140.45 $551,550 - $702,250	-5,000 Reduced 14.29%	30,000 $3.4 Million
Q1 2024 Apr 30, 2024	SELL	$114.22 - $140.1 $1.71 Million - $2.1 Million	-15,000 Reduced 30.0%	35,000 $4.86 Million
Q3 2023 Nov 06, 2023	BUY	$86.06 - $137.93 $4.3 Million - $6.9 Million	50,000 New	50,000 $4.67 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $348,000 - $486,500	-12,500 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$28.07 - $38.18 $140,350 - $190,900	5,000 Added 66.67%	12,500 $1.49 Million
Q4 2018 Feb 12, 2019	SELL	$26.99 - $37.37 $337,375 - $467,124	-12,500 Reduced 62.5%	7,500 $899,000
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $212,485 - $334,152	9,100 Added 83.49%	20,000 $2.86 Million
Q2 2018 Aug 06, 2018	BUY	$17.54 - $25.22 $191,186 - $274,898	10,900 New	10,900 $1.04 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.